The Medical Advisor

Watch the full interview video below (scroll to the bottom). Full Transcript Jan Jekielek: Dr. Kathleen Ruddy, such a pleasure to have you on American Thought Leaders. Dr. Kathleen Ruddy:  Thank you for having me. Mr. Jekielek:  You are deeply involved with the FLCCC [Front Line Covid-19 Critical Care Alliance] and you are also working on ivermectin as a possible treatment for cancer. This might be astonishing to some people. Ivermectin is a very famous drug for treating river blindness and has saved millions of lives. We know it’s effective for treating Covid-19, especially at its early stage. There have been a lot of studies done on this. Dr. Kathleen Ruddy:  I have to say that I was also astonished that ivermectin has potential as an anti-cancer agent. I’m a cancer surgeon. We don’t do parasites. We don’t do ivermectin. I was not really even familiar with those people who use ivermectin. In the early...

Cancer  kills around 10 million people a year  and is a leading cause of death globally, according to the World Health Organization. Cancer research continues to advance at an unprecedented pace, with new treatments offering hope to millions of patients worldwide.   Credit:  Statista Breast, lung and colon cancer are among the most common, while the number of new cancer cases annually is expected to grow by more than 75% between 2022 and 2050. As we enter 2025, several groundbreaking therapies and innovations—including personalized vaccines, gene-editing technologies, repurposed drugs, and alternative cancer treatments —are reshaping cancer care. Here are some of the most promising breakthroughs to watch for this year: 1. Next-Generation Immunotherapy Advances in immunotherapy continue to improve survival rates. Novel checkpoint inhibitors, CAR-T cell therapies, and bispecific antibodies are expanding treatment options for hard-to-treat cancers like pancreatic and b...